Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.669863416507743.
The log-likelihood improved by 2.938.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.8409.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1159.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       1       26     1299     1081      823      331      368      310 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     261      204      138       70       49       20       12        6 
degree16 
       1 
1 
disease_progression 
H-positive risk:  886 856 122 850 465 135 884 442 114 63 129 54 
H-negative risk:  856 886 884 850 442 465 135 122 129 114 54 63 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
68 new agents 
2 
disease_progression 
H-positive risk:  889 855 121 849 465 136 886 439 117 64 127 52 
H-negative risk:  855 889 886 849 439 465 136 121 127 117 52 64 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
50 new agents 
3 
disease_progression 
H-positive risk:  891 858 122 845 461 137 890 440 117 59 128 52 
H-negative risk:  858 891 890 845 440 461 137 122 128 117 52 59 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
55 new agents 
4 
disease_progression 
H-positive risk:  893 860 123 852 454 140 883 437 118 59 130 51 
H-negative risk:  860 893 883 852 437 454 140 123 130 118 51 59 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
55 new agents 
5 
disease_progression 
H-positive risk:  895 867 123 853 451 139 885 433 116 59 129 50 
H-negative risk:  867 895 885 853 433 451 139 123 129 116 50 59 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 6 

clinical_engagement 
diagnosis 
demography 
52 new agents 
6 
disease_progression 
H-positive risk:  896 874 122 853 448 140 880 436 115 59 127 50 
H-negative risk:  874 896 880 853 436 448 140 122 127 115 50 59 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 7 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
7 
disease_progression 
H-positive risk:  907 882 120 852 442 141 880 427 116 56 126 51 
H-negative risk:  882 907 880 852 427 442 141 120 126 116 51 56 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
47 new agents 
8 
disease_progression 
H-positive risk:  911 884 120 859 439 141 876 421 116 56 127 50 
H-negative risk:  884 911 876 859 421 439 141 120 127 116 50 56 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 12 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
9 
disease_progression 
H-positive risk:  914 897 121 859 435 141 866 422 117 54 124 50 
H-negative risk:  897 914 866 859 422 435 141 121 124 117 50 54 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 13 1 

clinical_engagement 
diagnosis 
demography 
70 new agents 
10 
disease_progression 
H-positive risk:  911 896 127 853 431 143 869 423 118 53 126 50 
H-negative risk:  896 911 869 853 423 431 143 127 126 118 50 53 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 14 1 

clinical_engagement 
diagnosis 
demography 
67 new agents 
11 
disease_progression 
H-positive risk:  913 902 130 854 426 143 866 418 121 52 127 48 
H-negative risk:  902 913 866 854 418 426 143 130 127 121 48 52 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 16 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
12 
disease_progression 
H-positive risk:  912 913 129 851 420 139 870 415 120 54 128 49 
H-negative risk:  913 912 870 851 415 420 139 129 128 120 49 54 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 17 1 

clinical_engagement 
diagnosis 
demography 
58 new agents 
13 
disease_progression 
H-positive risk:  839 820 116 944 417 122 953 415 136 54 140 44 
H-negative risk:  820 839 953 944 415 417 122 116 140 136 44 54 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 19 1 

clinical_engagement 
diagnosis 
demography 
241 new agents 
14 
disease_progression 
H-positive risk:  875 859 121 893 427 129 912 414 129 54 147 40 
H-negative risk:  859 875 912 893 414 427 129 121 147 129 40 54 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 23 2 

clinical_engagement 
diagnosis 
demography 
62 new agents 
15 
disease_progression 
H-positive risk:  880 864 122 898 424 132 907 406 127 53 147 40 
H-negative risk:  864 880 907 898 406 424 132 122 147 127 40 53 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 25 5 

clinical_engagement 
diagnosis 
demography 
59 new agents 
16 
disease_progression 
H-positive risk:  892 869 123 895 417 130 904 405 127 51 147 40 
H-negative risk:  869 892 904 895 405 417 130 123 147 127 40 51 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 26 6 

clinical_engagement 
diagnosis 
demography 
52 new agents 
17 
disease_progression 
H-positive risk:  902 877 122 894 420 128 892 404 126 50 146 39 
H-negative risk:  877 902 892 894 404 420 128 122 146 126 39 50 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 26 7 

clinical_engagement 
diagnosis 
demography 
52 new agents 
18 
disease_progression 
H-positive risk:  906 887 122 887 414 129 893 404 125 50 144 39 
H-negative risk:  887 906 893 887 404 414 129 122 144 125 39 50 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 28 6 

clinical_engagement 
diagnosis 
demography 
59 new agents 
19 
disease_progression 
H-positive risk:  908 893 124 891 409 130 889 403 125 47 143 38 
H-negative risk:  893 908 889 891 403 409 130 124 143 125 38 47 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 30 7 

clinical_engagement 
diagnosis 
demography 
66 new agents 
20 
disease_progression 
H-positive risk:  910 892 126 889 409 130 893 404 123 46 143 35 
H-negative risk:  892 910 893 889 404 409 130 126 143 123 35 46 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 30 8 

clinical_engagement 
diagnosis 
demography 
44 new agents 
21 
disease_progression 
H-positive risk:  913 900 126 890 405 129 892 401 122 44 144 34 
H-negative risk:  900 913 892 890 401 405 129 126 144 122 34 44 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 33 8 

clinical_engagement 
diagnosis 
demography 
56 new agents 
22 
disease_progression 
H-positive risk:  915 905 125 890 403 128 890 395 122 44 148 35 
H-negative risk:  905 915 890 890 395 403 128 125 148 122 35 44 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 34 8 

clinical_engagement 
diagnosis 
demography 
77 new agents 
23 
disease_progression 
H-positive risk:  926 912 124 877 402 129 887 394 120 44 150 35 
H-negative risk:  912 926 887 877 394 402 129 124 150 120 35 44 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 35 7 

clinical_engagement 
diagnosis 
demography 
60 new agents 
24 
disease_progression 
H-positive risk:  927 921 123 873 400 132 885 395 118 44 149 33 
H-negative risk:  921 927 885 873 395 400 132 123 149 118 33 44 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 38 7 

clinical_engagement 
diagnosis 
demography 
65 new agents 
25 
disease_progression 
H-positive risk:  864 854 110 948 398 124 945 391 132 43 158 33 
H-negative risk:  854 864 945 948 391 398 124 110 158 132 33 43 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 39 8 

clinical_engagement 
diagnosis 
demography 
171 new agents 
26 
disease_progression 
H-positive risk:  882 874 112 914 416 123 916 401 134 40 154 34 
H-negative risk:  874 882 916 914 401 416 123 112 154 134 34 40 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 44 7 

clinical_engagement 
diagnosis 
demography 
70 new agents 
27 
disease_progression 
H-positive risk:  881 878 113 915 411 122 914 401 137 40 153 35 
H-negative risk:  878 881 914 915 401 411 122 113 153 137 35 40 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 45 7 

clinical_engagement 
diagnosis 
demography 
56 new agents 
28 
disease_progression 
H-positive risk:  883 878 114 910 410 123 911 403 141 40 151 36 
H-negative risk:  878 883 911 910 403 410 123 114 151 141 36 40 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 45 8 

clinical_engagement 
diagnosis 
demography 
59 new agents 
29 
disease_progression 
H-positive risk:  885 880 114 907 409 125 908 403 143 42 149 35 
H-negative risk:  880 885 908 907 403 409 125 114 149 143 35 42 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 47 8 

clinical_engagement 
diagnosis 
demography 
47 new agents 
30 
disease_progression 
H-positive risk:  886 885 113 907 407 124 905 404 143 41 150 35 
H-negative risk:  885 886 905 907 404 407 124 113 150 143 35 41 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 47 8 

clinical_engagement 
diagnosis 
demography 
66 new agents 
31 
disease_progression 
H-positive risk:  891 891 114 907 405 123 903 399 139 44 149 35 
H-negative risk:  891 891 903 907 399 405 123 114 149 139 35 44 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 51 8 

clinical_engagement 
diagnosis 
demography 
58 new agents 
32 
disease_progression 
H-positive risk:  895 896 114 913 401 123 899 395 139 42 149 34 
H-negative risk:  896 895 899 913 395 401 123 114 149 139 34 42 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 52 8 

clinical_engagement 
diagnosis 
demography 
69 new agents 
33 
disease_progression 
H-positive risk:  896 900 116 914 399 124 898 392 137 41 149 34 
H-negative risk:  900 896 898 914 392 399 124 116 149 137 34 41 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 54 7 

clinical_engagement 
diagnosis 
demography 
53 new agents 
34 
disease_progression 
H-positive risk:  911 902 113 916 396 123 895 385 138 42 145 34 
H-negative risk:  902 911 895 916 385 396 123 113 145 138 34 42 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 57 7 

clinical_engagement 
diagnosis 
demography 
74 new agents 
35 
disease_progression 
H-positive risk:  922 905 114 908 398 123 889 384 137 42 142 36 
H-negative risk:  905 922 889 908 384 398 123 114 142 137 36 42 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 56 8 

clinical_engagement 
diagnosis 
demography 
60 new agents 
36 
disease_progression 
H-positive risk:  924 907 114 907 391 121 893 385 137 43 142 36 
H-negative risk:  907 924 893 907 385 391 121 114 142 137 36 43 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 58 9 

clinical_engagement 
diagnosis 
demography 
73 new agents 
37 
disease_progression 
H-positive risk:  862 859 103 947 392 110 958 382 152 43 157 35 
H-negative risk:  859 862 958 947 382 392 110 103 157 152 35 43 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 58 9 

clinical_engagement 
diagnosis 
demography 
158 new agents 
38 
disease_progression 
H-positive risk:  882 872 105 923 398 113 922 404 144 51 147 39 
H-negative risk:  872 882 922 923 404 398 113 105 147 144 39 51 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 60 9 

clinical_engagement 
diagnosis 
demography 
85 new agents 
39 
disease_progression 
H-positive risk:  879 876 106 918 394 115 923 404 144 52 149 40 
H-negative risk:  876 879 923 918 404 394 115 106 149 144 40 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 63 9 

clinical_engagement 
diagnosis 
demography 
57 new agents 
40 
disease_progression 
H-positive risk:  878 874 106 920 396 116 919 407 145 51 149 39 
H-negative risk:  874 878 919 920 407 396 116 106 149 145 39 51 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 61 13 

clinical_engagement 
diagnosis 
demography 
58 new agents 
41 
disease_progression 
H-positive risk:  882 876 105 928 392 116 921 398 146 52 145 39 
H-negative risk:  876 882 921 928 398 392 116 105 145 146 39 52 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
42 
disease_progression 
H-positive risk:  885 878 103 928 390 119 924 391 146 52 143 41 
H-negative risk:  878 885 924 928 391 390 119 103 143 146 41 52 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
62 new agents 
43 
disease_progression 
H-positive risk:  885 887 103 927 386 117 929 383 147 50 143 43 
H-negative risk:  887 885 929 927 383 386 117 103 143 147 43 50 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
57 new agents 
44 
disease_progression 
H-positive risk:  885 887 102 930 387 118 931 378 148 47 144 43 
H-negative risk:  887 885 931 930 378 387 118 102 144 148 43 47 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 66 13 

clinical_engagement 
diagnosis 
demography 
61 new agents 
45 
disease_progression 
H-positive risk:  885 890 104 926 387 117 934 380 146 45 143 43 
H-negative risk:  890 885 934 926 380 387 117 104 143 146 43 45 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
68 new agents 
46 
disease_progression 
H-positive risk:  892 896 102 934 388 118 924 370 145 46 143 42 
H-negative risk:  896 892 924 934 370 388 118 102 143 145 42 46 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
47 
disease_progression 
H-positive risk:  892 900 103 928 386 118 929 372 146 45 139 42 
H-negative risk:  900 892 929 928 372 386 118 103 139 146 42 45 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 64 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
48 
disease_progression 
H-positive risk:  892 903 104 922 377 119 932 376 147 45 140 43 
H-negative risk:  903 892 932 922 376 377 119 104 140 147 43 45 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 68 15 

clinical_engagement 
diagnosis 
demography 
54 new agents 
49 
disease_progression 
H-positive risk:  832 851 93 976 371 108 989 379 158 47 153 43 
H-negative risk:  851 832 989 976 379 371 108 93 153 158 43 47 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 69 15 

clinical_engagement 
diagnosis 
demography 
158 new agents 
50 
disease_progression 
H-positive risk:  834 864 95 959 382 114 969 392 146 49 144 52 
H-negative risk:  864 834 969 959 392 382 114 95 144 146 52 49 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 65 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
51 
disease_progression 
H-positive risk:  843 868 98 957 383 111 964 385 145 50 145 51 
H-negative risk:  868 843 964 957 385 383 111 98 145 145 51 50 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 64 16 

clinical_engagement 
diagnosis 
demography 
71 new agents 
52 
disease_progression 
H-positive risk:  848 867 99 962 377 113 959 383 146 52 143 51 
H-negative risk:  867 848 959 962 383 377 113 99 143 146 51 52 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 65 17 

clinical_engagement 
diagnosis 
demography 
60 new agents 
53 
disease_progression 
H-positive risk:  848 875 101 963 377 113 956 379 144 53 139 52 
H-negative risk:  875 848 956 963 379 377 113 101 139 144 52 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
54 
disease_progression 
H-positive risk:  852 876 102 964 369 119 964 371 144 51 136 52 
H-negative risk:  876 852 964 964 371 369 119 102 136 144 52 51 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 63 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
55 
disease_progression 
H-positive risk:  862 876 101 965 367 117 953 373 145 52 139 50 
H-negative risk:  876 862 953 965 373 367 117 101 139 145 50 52 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 61 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
56 
disease_progression 
H-positive risk:  858 871 102 977 367 116 946 373 145 50 142 53 
H-negative risk:  871 858 946 977 373 367 116 102 142 145 53 50 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
57 new agents 
57 
disease_progression 
H-positive risk:  850 874 101 974 365 116 961 369 145 49 144 52 
H-negative risk:  874 850 961 974 369 365 116 101 144 145 52 49 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 63 19 

clinical_engagement 
diagnosis 
demography 
57 new agents 
58 
disease_progression 
H-positive risk:  854 879 102 974 362 114 956 370 144 51 142 52 
H-negative risk:  879 854 956 974 370 362 114 102 142 144 52 51 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 65 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
59 
disease_progression 
H-positive risk:  851 877 101 972 364 114 958 375 144 52 141 51 
H-negative risk:  877 851 958 972 375 364 114 101 141 144 51 52 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
58 new agents 
60 
disease_progression 
H-positive risk:  853 887 101 975 356 114 956 376 142 51 140 49 
H-negative risk:  887 853 956 975 376 356 114 101 140 142 49 51 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 66 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
61 
disease_progression 
H-positive risk:  799 828 93 1034 353 108 1018 371 148 49 149 50 
H-negative risk:  828 799 1018 1034 371 353 108 93 149 148 50 49 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 65 21 

clinical_engagement 
diagnosis 
demography 
111 new agents 
62 
disease_progression 
H-positive risk:  805 830 98 1018 365 105 1000 383 148 54 144 50 
H-negative risk:  830 805 1000 1018 383 365 105 98 144 148 50 54 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 64 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
63 
disease_progression 
H-positive risk:  805 835 97 1011 364 107 1007 381 144 56 144 49 
H-negative risk:  835 805 1007 1011 381 364 107 97 144 144 49 56 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 64 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
64 
disease_progression 
H-positive risk:  813 832 100 1006 370 108 999 377 143 56 147 49 
H-negative risk:  832 813 999 1006 377 370 108 100 147 143 49 56 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 59 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
65 
disease_progression 
H-positive risk:  818 836 98 1003 374 110 1000 370 142 56 147 46 
H-negative risk:  836 818 1000 1003 370 374 110 98 147 142 46 56 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 57 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
66 
disease_progression 
H-positive risk:  821 833 98 1003 379 108 1002 363 141 58 147 47 
H-negative risk:  833 821 1002 1003 363 379 108 98 147 141 47 58 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
67 
disease_progression 
H-positive risk:  823 832 99 1006 374 110 998 365 143 59 143 48 
H-negative risk:  832 823 998 1006 365 374 110 99 143 143 48 59 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 53 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
68 
disease_progression 
H-positive risk:  834 834 102 1001 377 110 993 360 138 60 144 47 
H-negative risk:  834 834 993 1001 360 377 110 102 144 138 47 60 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 51 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
69 
disease_progression 
H-positive risk:  838 837 100 995 381 111 999 352 136 60 141 50 
H-negative risk:  837 838 999 995 352 381 111 100 141 136 50 60 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 52 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
70 
disease_progression 
H-positive risk:  839 846 105 990 376 108 1003 345 138 60 140 50 
H-negative risk:  846 839 1003 990 345 376 108 105 140 138 50 60 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 51 25 

clinical_engagement 
diagnosis 
demography 
52 new agents 
71 
disease_progression 
H-positive risk:  837 845 105 992 376 108 1003 347 137 60 140 50 
H-negative risk:  845 837 1003 992 347 376 108 105 140 137 50 60 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 52 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
72 
disease_progression 
H-positive risk:  841 852 108 996 380 110 985 347 136 59 138 48 
H-negative risk:  852 841 985 996 347 380 110 108 138 136 48 59 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 53 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
73 
disease_progression 
H-positive risk:  780 809 100 1040 384 106 1048 340 144 59 143 47 
H-negative risk:  809 780 1048 1040 340 384 106 100 143 144 47 59 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 52 26 

clinical_engagement 
diagnosis 
demography 
109 new agents 
74 
disease_progression 
H-positive risk:  781 813 101 1022 389 107 1022 364 142 63 145 51 
H-negative risk:  813 781 1022 1022 364 389 107 101 145 142 51 63 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 49 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
75 
disease_progression 
H-positive risk:  787 819 98 1023 394 109 1012 362 142 61 144 49 
H-negative risk:  819 787 1012 1023 362 394 109 98 144 142 49 61 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 48 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
76 
disease_progression 
H-positive risk:  789 823 96 1027 392 110 1001 363 142 62 148 47 
H-negative risk:  823 789 1001 1027 363 392 110 96 148 142 47 62 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 49 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
77 
disease_progression 
H-positive risk:  794 825 96 1025 389 110 996 365 138 65 151 46 
H-negative risk:  825 794 996 1025 365 389 110 96 151 138 46 65 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 49 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
78 
disease_progression 
H-positive risk:  795 828 97 1017 393 114 997 362 137 65 150 45 
H-negative risk:  828 795 997 1017 362 393 114 97 150 137 45 65 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 47 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
79 
disease_progression 
H-positive risk:  794 840 97 1013 395 117 981 359 139 63 156 46 
H-negative risk:  840 794 981 1013 359 395 117 97 156 139 46 63 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
80 
disease_progression 
H-positive risk:  789 836 93 1021 396 118 982 353 140 65 158 49 
H-negative risk:  836 789 982 1021 353 396 118 93 158 140 49 65 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 49 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
81 
disease_progression 
H-positive risk:  795 832 96 1022 394 117 981 354 143 67 151 48 
H-negative risk:  832 795 981 1022 354 394 117 96 151 143 48 67 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
99 new agents 
82 
disease_progression 
H-positive risk:  796 849 94 1023 378 120 980 355 143 63 151 48 
H-negative risk:  849 796 980 1023 355 378 120 94 151 143 48 63 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 53 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
83 
disease_progression 
H-positive risk:  798 856 96 1028 370 123 978 347 142 64 149 49 
H-negative risk:  856 798 978 1028 347 370 123 96 149 142 49 64 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 55 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
84 
disease_progression 
H-positive risk:  796 862 97 1028 370 126 966 351 144 63 150 47 
H-negative risk:  862 796 966 1028 351 370 126 97 150 144 47 63 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
85 
disease_progression 
H-positive risk:  749 815 89 1075 367 125 1017 348 146 63 160 46 
H-negative risk:  815 749 1017 1075 348 367 125 89 160 146 46 63 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
109 new agents 
86 
disease_progression 
H-positive risk:  754 804 89 1060 381 124 997 373 142 64 156 56 
H-negative risk:  804 754 997 1060 373 381 124 89 156 142 56 64 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
87 
disease_progression 
H-positive risk:  750 803 90 1059 380 125 1003 372 142 61 159 56 
H-negative risk:  803 750 1003 1059 372 380 125 90 159 142 56 61 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 55 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
88 
disease_progression 
H-positive risk:  744 810 91 1055 378 121 1001 378 143 62 160 57 
H-negative risk:  810 744 1001 1055 378 378 121 91 160 143 57 62 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 55 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
89 
disease_progression 
H-positive risk:  747 811 90 1046 378 123 1002 383 143 62 159 56 
H-negative risk:  811 747 1002 1046 383 378 123 90 159 143 56 62 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
90 
disease_progression 
H-positive risk:  749 811 92 1041 375 124 1005 382 144 63 158 56 
H-negative risk:  811 749 1005 1041 382 375 124 92 158 144 56 63 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
91 
disease_progression 
H-positive risk:  751 810 92 1046 373 126 1002 386 142 61 157 54 
H-negative risk:  810 751 1002 1046 386 373 126 92 157 142 54 61 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 54 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
92 
disease_progression 
H-positive risk:  760 810 94 1035 373 125 1006 387 141 60 158 51 
H-negative risk:  810 760 1006 1035 387 373 125 94 158 141 51 60 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
93 
disease_progression 
H-positive risk:  764 815 93 1034 365 126 1012 386 141 58 156 50 
H-negative risk:  815 764 1012 1034 386 365 126 93 156 141 50 58 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
94 
disease_progression 
H-positive risk:  756 807 94 1041 363 124 1026 383 141 58 157 50 
H-negative risk:  807 756 1026 1041 383 363 124 94 157 141 50 58 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 54 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
95 
disease_progression 
H-positive risk:  763 809 93 1045 371 123 1015 380 141 56 154 50 
H-negative risk:  809 763 1015 1045 380 371 123 93 154 141 50 56 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 52 21 

clinical_engagement 
diagnosis 
demography 
57 new agents 
96 
disease_progression 
H-positive risk:  752 802 93 1050 370 122 1024 382 142 55 157 51 
H-negative risk:  802 752 1024 1050 382 370 122 93 157 142 51 55 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 54 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
97 
disease_progression 
H-positive risk:  707 757 90 1096 371 114 1074 379 144 56 163 49 
H-negative risk:  757 707 1074 1096 379 371 114 90 163 144 49 56 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 54 21 

clinical_engagement 
diagnosis 
demography 
97 new agents 
98 
disease_progression 
H-positive risk:  711 749 88 1086 381 112 1061 402 142 57 160 51 
H-negative risk:  749 711 1061 1086 402 381 112 88 160 142 51 57 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
99 
disease_progression 
H-positive risk:  712 758 89 1084 380 112 1057 402 137 56 159 54 
H-negative risk:  758 712 1057 1084 402 380 112 89 159 137 54 56 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
100 
disease_progression 
H-positive risk:  708 759 91 1077 389 112 1061 399 135 57 158 54 
H-negative risk:  759 708 1061 1077 399 389 112 91 158 135 54 57 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 55 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
101 
disease_progression 
H-positive risk:  710 770 94 1071 387 112 1057 392 137 56 159 55 
H-negative risk:  770 710 1057 1071 392 387 112 94 159 137 55 56 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 56 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  712 763 95 1077 395 112 1054 385 140 57 157 53 
H-negative risk:  763 712 1054 1077 385 395 112 95 157 140 53 57 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 53 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
103 
disease_progression 
H-positive risk:  717 760 97 1080 393 111 1055 385 139 58 153 52 
H-negative risk:  760 717 1055 1080 385 393 111 97 153 139 52 58 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 54 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
104 
disease_progression 
H-positive risk:  721 757 95 1077 395 111 1066 377 138 55 155 53 
H-negative risk:  757 721 1066 1077 377 395 111 95 155 138 53 55 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 53 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
105 
disease_progression 
H-positive risk:  726 754 93 1087 396 111 1064 366 134 58 155 56 
H-negative risk:  754 726 1064 1087 366 396 111 93 155 134 56 58 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 57 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
106 
disease_progression 
H-positive risk:  722 757 94 1085 391 111 1068 366 132 60 158 56 
H-negative risk:  757 722 1068 1085 366 391 111 94 158 132 56 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 58 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
107 
disease_progression 
H-positive risk:  725 765 94 1079 393 111 1062 369 128 59 159 56 
H-negative risk:  765 725 1062 1079 369 393 111 94 159 128 56 59 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
108 
disease_progression 
H-positive risk:  732 764 93 1065 398 111 1065 368 131 57 162 54 
H-negative risk:  764 732 1065 1065 368 398 111 93 162 131 54 57 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
109 
disease_progression 
H-positive risk:  697 733 90 1096 399 102 1104 363 141 58 164 53 
H-negative risk:  733 697 1104 1096 363 399 102 90 164 141 53 58 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
110 
disease_progression 
H-positive risk:  692 724 86 1101 410 101 1089 378 134 62 166 57 
H-negative risk:  724 692 1089 1101 378 410 101 86 166 134 57 62 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 62 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
111 
disease_progression 
H-positive risk:  694 727 88 1101 411 102 1087 373 135 63 160 59 
H-negative risk:  727 694 1087 1101 373 411 102 88 160 135 59 63 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
112 
disease_progression 
H-positive risk:  703 729 87 1094 410 99 1083 378 138 59 158 62 
H-negative risk:  729 703 1083 1094 378 410 99 87 158 138 62 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
64 new agents 
113 
disease_progression 
H-positive risk:  712 726 86 1103 401 96 1079 382 139 58 158 60 
H-negative risk:  726 712 1079 1103 382 401 96 86 158 139 60 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 63 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
114 
disease_progression 
H-positive risk:  702 726 85 1111 389 98 1093 376 139 60 161 60 
H-negative risk:  726 702 1093 1111 376 389 98 85 161 139 60 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 62 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
115 
disease_progression 
H-positive risk:  704 738 85 1109 380 95 1096 374 138 61 160 60 
H-negative risk:  738 704 1096 1109 374 380 95 85 160 138 60 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 64 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
116 
disease_progression 
H-positive risk:  703 736 86 1117 382 100 1097 361 134 64 161 59 
H-negative risk:  736 703 1097 1117 361 382 100 86 161 134 59 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
117 
disease_progression 
H-positive risk:  704 736 88 1116 376 101 1094 365 139 65 159 57 
H-negative risk:  736 704 1094 1116 365 376 101 88 159 139 57 65 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 64 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
118 
disease_progression 
H-positive risk:  711 725 87 1132 369 102 1090 369 138 64 157 56 
H-negative risk:  725 711 1090 1132 369 369 102 87 157 138 56 64 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 60 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
119 
disease_progression 
H-positive risk:  708 730 88 1126 371 104 1087 368 141 64 158 55 
H-negative risk:  730 708 1087 1126 368 371 104 88 158 141 55 64 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 61 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
120 
disease_progression 
H-positive risk:  707 733 87 1117 372 105 1095 369 140 60 159 56 
H-negative risk:  733 707 1095 1117 369 372 105 87 159 140 56 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 65 29 

clinical_engagement 
diagnosis 
demography 
58 new agents 
121 
disease_progression 
H-positive risk:  658 696 82 1157 373 97 1135 372 148 62 163 57 
H-negative risk:  696 658 1135 1157 372 373 97 82 163 148 57 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
122 
disease_progression 
H-positive risk:  664 691 79 1159 367 99 1127 382 147 61 164 60 
H-negative risk:  691 664 1127 1159 382 367 99 79 164 147 60 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
123 
disease_progression 
H-positive risk:  673 694 79 1151 370 101 1124 386 141 63 159 59 
H-negative risk:  694 673 1124 1151 386 370 101 79 159 141 59 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
124 
disease_progression 
H-positive risk:  681 701 78 1148 357 102 1126 383 140 61 165 58 
H-negative risk:  701 681 1126 1148 383 357 102 78 165 140 58 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
125 
disease_progression 
H-positive risk:  679 700 78 1146 357 104 1121 389 141 61 166 58 
H-negative risk:  700 679 1121 1146 389 357 104 78 166 141 58 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
126 
disease_progression 
H-positive risk:  676 707 80 1155 350 100 1121 388 142 58 164 59 
H-negative risk:  707 676 1121 1155 388 350 100 80 164 142 59 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
127 
disease_progression 
H-positive risk:  673 705 78 1158 354 100 1116 389 142 61 166 58 
H-negative risk:  705 673 1116 1158 389 354 100 78 166 142 58 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
128 
disease_progression 
H-positive risk:  673 707 78 1155 355 103 1120 384 143 59 163 60 
H-negative risk:  707 673 1120 1155 384 355 103 78 163 143 60 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
129 
disease_progression 
H-positive risk:  677 704 79 1160 356 101 1120 378 145 60 164 56 
H-negative risk:  704 677 1120 1160 378 356 101 79 164 145 56 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
69 new agents 
130 
disease_progression 
H-positive risk:  670 698 79 1157 362 100 1126 380 144 61 166 57 
H-negative risk:  698 670 1126 1157 380 362 100 79 166 144 57 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
54 new agents 
131 
disease_progression 
H-positive risk:  673 698 79 1157 365 99 1123 377 147 60 166 56 
H-negative risk:  698 673 1123 1157 377 365 99 79 166 147 56 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
61 new agents 
132 
disease_progression 
H-positive risk:  675 698 80 1159 360 98 1121 380 147 59 167 56 
H-negative risk:  698 675 1121 1159 380 360 98 80 167 147 56 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
133 
disease_progression 
H-positive risk:  676 697 84 1149 363 97 1126 378 148 57 165 60 
H-negative risk:  697 676 1126 1149 378 363 97 84 165 148 60 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
134 
disease_progression 
H-positive risk:  659 699 84 1138 370 94 1122 395 155 59 161 64 
H-negative risk:  699 659 1122 1138 395 370 94 84 161 155 64 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
135 
disease_progression 
H-positive risk:  667 705 83 1133 364 91 1118 403 155 59 160 62 
H-negative risk:  705 667 1118 1133 403 364 91 83 160 155 62 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
136 
disease_progression 
H-positive risk:  662 709 85 1131 362 93 1120 402 154 61 161 60 
H-negative risk:  709 662 1120 1131 402 362 93 85 161 154 60 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
137 
disease_progression 
H-positive risk:  663 713 85 1125 364 93 1118 402 154 61 164 58 
H-negative risk:  713 663 1118 1125 402 364 93 85 164 154 58 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
138 
disease_progression 
H-positive risk:  666 711 85 1121 360 93 1116 405 156 61 169 57 
H-negative risk:  711 666 1116 1121 405 360 93 85 169 156 57 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
139 
disease_progression 
H-positive risk:  667 710 84 1117 364 94 1119 400 156 62 169 58 
H-negative risk:  710 667 1119 1117 400 364 94 84 169 156 58 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
140 
disease_progression 
H-positive risk:  668 718 83 1116 355 92 1124 399 160 60 168 57 
H-negative risk:  718 668 1124 1116 399 355 92 83 168 160 57 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 80 29 

clinical_engagement 
diagnosis 
demography 
68 new agents 
141 
disease_progression 
H-positive risk:  671 715 83 1120 348 96 1123 398 163 59 169 55 
H-negative risk:  715 671 1123 1120 398 348 96 83 169 163 55 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
142 
disease_progression 
H-positive risk:  664 721 84 1115 343 96 1131 402 159 58 169 58 
H-negative risk:  721 664 1131 1115 402 343 96 84 169 159 58 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
143 
disease_progression 
H-positive risk:  678 710 82 1116 345 96 1131 397 160 58 170 57 
H-negative risk:  710 678 1131 1116 397 345 96 82 170 160 57 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
144 
disease_progression 
H-positive risk:  670 709 86 1119 352 96 1134 389 158 61 169 57 
H-negative risk:  709 670 1134 1119 389 352 96 86 169 158 57 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
145 
disease_progression 
H-positive risk:  671 712 86 1118 351 99 1131 394 156 61 166 55 
H-negative risk:  712 671 1131 1118 394 351 99 86 166 156 55 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
109 new agents 
146 
disease_progression 
H-positive risk:  678 718 85 1112 350 100 1114 404 158 60 166 55 
H-negative risk:  718 678 1114 1112 404 350 100 85 166 158 55 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
89 new agents 
147 
disease_progression 
H-positive risk:  679 718 84 1108 355 101 1107 402 158 64 166 58 
H-negative risk:  718 679 1107 1108 402 355 101 84 166 158 58 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
148 
disease_progression 
H-positive risk:  671 717 85 1120 351 99 1112 401 160 60 165 59 
H-negative risk:  717 671 1112 1120 401 351 99 85 165 160 59 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
149 
disease_progression 
H-positive risk:  673 728 82 1116 349 100 1117 399 157 61 161 57 
H-negative risk:  728 673 1117 1116 399 349 100 82 161 157 57 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
150 
disease_progression 
H-positive risk:  679 728 83 1111 350 99 1118 396 157 60 162 57 
H-negative risk:  728 679 1118 1111 396 350 99 83 162 157 57 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
151 
disease_progression 
H-positive risk:  683 723 85 1108 352 99 1120 390 159 60 164 57 
H-negative risk:  723 683 1120 1108 390 352 99 85 164 159 57 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
54 new agents 
152 
disease_progression 
H-positive risk:  685 723 85 1111 347 97 1128 384 159 59 166 56 
H-negative risk:  723 685 1128 1111 384 347 97 85 166 159 56 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
62 new agents 
153 
disease_progression 
H-positive risk:  686 718 84 1119 346 96 1127 383 156 62 167 56 
H-negative risk:  718 686 1127 1119 383 346 96 84 167 156 56 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
154 
disease_progression 
H-positive risk:  683 704 84 1133 346 97 1134 378 154 62 169 56 
H-negative risk:  704 683 1134 1133 378 346 97 84 169 154 56 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
155 
disease_progression 
H-positive risk:  681 708 85 1131 346 99 1136 377 154 62 167 54 
H-negative risk:  708 681 1136 1131 377 346 99 85 167 154 54 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
156 
disease_progression 
H-positive risk:  682 708 83 1133 349 97 1134 373 155 61 172 53 
H-negative risk:  708 682 1134 1133 373 349 97 83 172 155 53 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
157 
disease_progression 
H-positive risk:  672 706 81 1140 344 97 1141 378 157 60 171 53 
H-negative risk:  706 672 1141 1140 378 344 97 81 171 157 53 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
158 
disease_progression 
H-positive risk:  675 698 79 1146 349 96 1137 383 153 63 170 51 
H-negative risk:  698 675 1137 1146 383 349 96 79 170 153 51 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 78 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
159 
disease_progression 
H-positive risk:  678 691 79 1146 356 94 1139 385 152 63 167 50 
H-negative risk:  691 678 1139 1146 385 356 94 79 167 152 50 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
160 
disease_progression 
H-positive risk:  681 689 80 1147 355 98 1148 375 150 60 167 50 
H-negative risk:  689 681 1148 1147 375 355 98 80 167 150 50 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 81 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
161 
disease_progression 
H-positive risk:  681 677 81 1142 362 98 1150 385 150 60 164 50 
H-negative risk:  677 681 1150 1142 385 362 98 81 164 150 50 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
162 
disease_progression 
H-positive risk:  677 675 83 1138 362 96 1156 391 150 63 162 47 
H-negative risk:  675 677 1156 1138 391 362 96 83 162 150 47 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
163 
disease_progression 
H-positive risk:  675 681 82 1135 357 97 1153 401 149 64 161 45 
H-negative risk:  681 675 1153 1135 401 357 97 82 161 149 45 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
61 new agents 
164 
disease_progression 
H-positive risk:  664 672 82 1130 362 101 1160 407 147 65 161 49 
H-negative risk:  672 664 1160 1130 407 362 101 82 161 147 49 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
165 
disease_progression 
H-positive risk:  673 669 80 1132 359 101 1158 403 148 63 164 50 
H-negative risk:  669 673 1158 1132 403 359 101 80 164 148 50 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
166 
disease_progression 
H-positive risk:  670 661 81 1136 362 99 1158 403 152 65 160 53 
H-negative risk:  661 670 1158 1136 403 362 99 81 160 152 53 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
167 
disease_progression 
H-positive risk:  680 664 80 1133 353 97 1151 398 160 67 159 58 
H-negative risk:  664 680 1151 1133 398 353 97 80 159 160 58 67 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 90 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
168 
disease_progression 
H-positive risk:  680 656 81 1139 351 96 1150 399 166 67 160 55 
H-negative risk:  656 680 1150 1139 399 351 96 81 160 166 55 67 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
169 
disease_progression 
H-positive risk:  676 656 84 1141 345 93 1159 398 164 69 158 57 
H-negative risk:  656 676 1159 1141 398 345 93 84 158 164 57 69 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
170 
disease_progression 
H-positive risk:  669 659 82 1130 360 95 1156 398 164 71 156 60 
H-negative risk:  659 669 1156 1130 398 360 95 82 156 164 60 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
171 
disease_progression 
H-positive risk:  666 657 86 1133 351 94 1172 392 164 71 153 61 
H-negative risk:  657 666 1172 1133 392 351 94 86 153 164 61 71 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
172 
disease_progression 
H-positive risk:  665 664 87 1140 350 95 1168 385 159 73 154 60 
H-negative risk:  664 665 1168 1140 385 350 95 87 154 159 60 73 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 90 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
173 
disease_progression 
H-positive risk:  664 657 89 1139 355 97 1164 391 157 74 154 59 
H-negative risk:  657 664 1164 1139 391 355 97 89 154 157 59 74 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 90 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
174 
disease_progression 
H-positive risk:  668 659 87 1137 358 97 1158 393 156 72 157 58 
H-negative risk:  659 668 1158 1137 393 358 97 87 157 156 58 72 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 93 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
175 
disease_progression 
H-positive risk:  664 653 87 1141 359 102 1162 396 153 69 155 59 
H-negative risk:  653 664 1162 1141 396 359 102 87 155 153 59 69 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 95 32 

clinical_engagement 
diagnosis 
demography 
77 new agents 
176 
disease_progression 
H-positive risk:  672 658 85 1136 360 101 1159 392 151 68 158 60 
H-negative risk:  658 672 1159 1136 392 360 101 85 158 151 60 68 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 94 34 

clinical_engagement 
diagnosis 
demography 
70 new agents 
177 
disease_progression 
H-positive risk:  664 661 85 1136 361 98 1172 393 152 63 158 57 
H-negative risk:  661 664 1172 1136 393 361 98 85 158 152 57 63 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 96 35 

clinical_engagement 
diagnosis 
demography 
82 new agents 
178 
disease_progression 
H-positive risk:  660 664 84 1137 359 97 1174 393 151 65 159 57 
H-negative risk:  664 660 1174 1137 393 359 97 84 159 151 57 65 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 96 35 

clinical_engagement 
diagnosis 
demography 
62 new agents 
179 
disease_progression 
H-positive risk:  659 665 84 1143 362 95 1171 388 151 65 160 57 
H-negative risk:  665 659 1171 1143 388 362 95 84 160 151 57 65 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 92 37 

clinical_engagement 
diagnosis 
demography 
68 new agents 
180 
disease_progression 
H-positive risk:  652 668 84 1149 363 94 1173 385 150 65 160 57 
H-negative risk:  668 652 1173 1149 385 363 94 84 160 150 57 65 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 93 38 

clinical_engagement 
diagnosis 
demography 
71 new agents 
181 
disease_progression 
H-positive risk:  651 675 86 1151 364 92 1170 380 153 61 160 57 
H-negative risk:  675 651 1170 1151 380 364 92 86 160 153 57 61 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 94 38 

clinical_engagement 
diagnosis 
demography 
78 new agents 
182 
disease_progression 
H-positive risk:  649 680 87 1138 378 91 1169 383 150 61 162 52 
H-negative risk:  680 649 1169 1138 383 378 91 87 162 150 52 61 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 93 38 

clinical_engagement 
diagnosis 
demography 
82 new agents 
183 
disease_progression 
H-positive risk:  647 686 87 1137 370 94 1171 385 145 61 161 56 
H-negative risk:  686 647 1171 1137 385 370 94 87 161 145 56 61 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 95 36 

clinical_engagement 
diagnosis 
demography 
64 new agents 
184 
disease_progression 
H-positive risk:  651 693 87 1135 371 91 1160 394 146 56 159 57 
H-negative risk:  693 651 1160 1135 394 371 91 87 159 146 57 56 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 91 35 

clinical_engagement 
diagnosis 
demography 
75 new agents 
185 
disease_progression 
H-positive risk:  653 685 89 1140 369 91 1158 401 143 54 161 56 
H-negative risk:  685 653 1158 1140 401 369 91 89 161 143 56 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 94 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
186 
disease_progression 
H-positive risk:  656 686 91 1131 376 90 1160 390 148 54 163 55 
H-negative risk:  686 656 1160 1131 390 376 90 91 163 148 55 54 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 92 37 

clinical_engagement 
diagnosis 
demography 
65 new agents 
187 
disease_progression 
H-positive risk:  654 680 92 1135 380 89 1155 395 149 54 160 57 
H-negative risk:  680 654 1155 1135 395 380 89 92 160 149 57 54 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 93 37 

clinical_engagement 
diagnosis 
demography 
70 new agents 
188 
disease_progression 
H-positive risk:  655 679 90 1139 378 88 1158 393 150 59 158 53 
H-negative risk:  679 655 1158 1139 393 378 88 90 158 150 53 59 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 93 36 

clinical_engagement 
diagnosis 
demography 
70 new agents 
189 
disease_progression 
H-positive risk:  657 688 90 1140 377 87 1146 388 152 59 161 55 
H-negative risk:  688 657 1146 1140 388 377 87 90 161 152 55 59 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 94 36 

clinical_engagement 
diagnosis 
demography 
66 new agents 
190 
disease_progression 
H-positive risk:  659 692 93 1132 376 86 1150 391 153 58 157 53 
H-negative risk:  692 659 1150 1132 391 376 86 93 157 153 53 58 
New BC onsets:  133
BC status:  4867 133 
BC subtype:  4867 97 36 

clinical_engagement 
diagnosis 
demography 
71 new agents 
191 
disease_progression 
H-positive risk:  654 689 92 1149 377 89 1135 399 153 53 154 56 
H-negative risk:  689 654 1135 1149 399 377 89 92 154 153 56 53 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 98 34 

clinical_engagement 
diagnosis 
demography 
79 new agents 
192 
disease_progression 
H-positive risk:  667 689 92 1146 378 87 1126 403 153 53 153 53 
H-negative risk:  689 667 1126 1146 403 378 87 92 153 153 53 53 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 95 33 

clinical_engagement 
diagnosis 
demography 
82 new agents 
193 
disease_progression 
H-positive risk:  667 691 91 1154 373 87 1126 404 152 50 152 53 
H-negative risk:  691 667 1126 1154 404 373 87 91 152 152 53 50 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 93 33 

clinical_engagement 
diagnosis 
demography 
81 new agents 
194 
disease_progression 
H-positive risk:  667 685 87 1158 380 86 1117 417 152 52 147 52 
H-negative risk:  685 667 1117 1158 417 380 86 87 147 152 52 52 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
195 
disease_progression 
H-positive risk:  664 678 86 1149 397 83 1117 421 153 53 146 53 
H-negative risk:  678 664 1117 1149 421 397 83 86 146 153 53 53 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
86 new agents 
196 
disease_progression 
H-positive risk:  655 678 81 1149 398 85 1125 419 152 52 152 54 
H-negative risk:  678 655 1125 1149 419 398 85 81 152 152 54 52 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
81 new agents 
197 
disease_progression 
H-positive risk:  647 679 81 1154 399 85 1131 417 151 51 151 54 
H-negative risk:  679 647 1131 1154 417 399 85 81 151 151 54 51 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
61 new agents 
198 
disease_progression 
H-positive risk:  648 677 80 1154 400 85 1130 416 148 50 158 54 
H-negative risk:  677 648 1130 1154 416 400 85 80 158 148 54 50 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 89 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
199 
disease_progression 
H-positive risk:  647 674 80 1150 410 84 1123 420 147 51 160 54 
H-negative risk:  674 647 1123 1150 420 410 84 80 160 147 54 51 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 91 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
200 
disease_progression 
H-positive risk:  645 667 79 1151 411 86 1123 423 147 51 160 57 
H-negative risk:  667 645 1123 1151 423 411 86 79 160 147 57 51 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 93 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
201 
disease_progression 
H-positive risk:  649 662 79 1148 422 88 1116 425 146 49 159 57 
H-negative risk:  662 649 1116 1148 425 422 88 79 159 146 57 49 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 95 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
202 
disease_progression 
H-positive risk:  638 663 79 1151 433 86 1118 419 153 47 156 57 
H-negative risk:  663 638 1118 1151 419 433 86 79 156 153 57 47 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 93 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
203 
disease_progression 
H-positive risk:  649 665 79 1144 437 90 1109 418 152 47 152 58 
H-negative risk:  665 649 1109 1144 418 437 90 79 152 152 58 47 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 91 34 

clinical_engagement 
diagnosis 
demography 
89 new agents 
204 
disease_progression 
H-positive risk:  658 668 82 1145 434 88 1105 418 151 45 144 62 
H-negative risk:  668 658 1105 1145 418 434 88 82 144 151 62 45 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 90 34 

clinical_engagement 
diagnosis 
demography 
99 new agents 
205 
disease_progression 
H-positive risk:  664 680 84 1147 432 84 1094 414 151 46 144 60 
H-negative risk:  680 664 1094 1147 414 432 84 84 144 151 60 46 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 90 36 

clinical_engagement 
diagnosis 
demography 
80 new agents 
206 
disease_progression 
H-positive risk:  671 673 83 1136 444 82 1077 438 148 49 140 59 
H-negative risk:  673 671 1077 1136 438 444 82 83 140 148 59 49 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 92 33 

clinical_engagement 
diagnosis 
demography 
88 new agents 
207 
disease_progression 
H-positive risk:  677 675 83 1134 444 82 1068 440 148 52 136 61 
H-negative risk:  675 677 1068 1134 440 444 82 83 136 148 61 52 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 94 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
208 
disease_progression 
H-positive risk:  674 675 88 1130 443 81 1078 429 155 51 135 61 
H-negative risk:  675 674 1078 1130 429 443 81 88 135 155 61 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 91 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
209 
disease_progression 
H-positive risk:  673 682 90 1130 438 83 1076 433 151 51 133 60 
H-negative risk:  682 673 1076 1130 433 438 83 90 133 151 60 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
210 
disease_progression 
H-positive risk:  672 687 91 1130 431 84 1080 431 152 48 135 59 
H-negative risk:  687 672 1080 1130 431 431 84 91 135 152 59 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 93 28 

clinical_engagement 
diagnosis 
demography 
96 new agents 
211 
disease_progression 
H-positive risk:  676 685 91 1125 434 82 1077 438 151 47 134 60 
H-negative risk:  685 676 1077 1125 438 434 82 91 134 151 60 47 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
212 
disease_progression 
H-positive risk:  675 685 92 1133 425 86 1079 435 151 46 135 58 
H-negative risk:  685 675 1079 1133 435 425 86 92 135 151 58 46 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
213 
disease_progression 
H-positive risk:  675 677 91 1140 426 85 1077 433 154 46 134 62 
H-negative risk:  677 675 1077 1140 433 426 85 91 134 154 62 46 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
214 
disease_progression 
H-positive risk:  672 678 90 1132 439 86 1082 424 153 47 135 62 
H-negative risk:  678 672 1082 1132 424 439 86 90 135 153 62 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
215 
disease_progression 
H-positive risk:  665 680 89 1131 440 88 1082 423 158 49 136 59 
H-negative risk:  680 665 1082 1131 423 440 88 89 136 158 59 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
216 
disease_progression 
H-positive risk:  671 678 86 1130 438 87 1087 414 159 51 137 62 
H-negative risk:  678 671 1087 1130 414 438 87 86 137 159 62 51 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
217 
disease_progression 
H-positive risk:  673 665 84 1120 455 92 1081 427 158 49 136 60 
H-negative risk:  665 673 1081 1120 427 455 92 84 136 158 60 49 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
218 
disease_progression 
H-positive risk:  670 668 86 1114 454 92 1087 424 159 48 136 62 
H-negative risk:  668 670 1087 1114 424 454 92 86 136 159 62 48 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 94 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
219 
disease_progression 
H-positive risk:  679 667 86 1110 457 93 1087 418 161 47 135 60 
H-negative risk:  667 679 1087 1110 418 457 93 86 135 161 60 47 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
220 
disease_progression 
H-positive risk:  674 662 86 1112 455 95 1089 416 166 47 135 63 
H-negative risk:  662 674 1089 1112 416 455 95 86 135 166 63 47 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
221 
disease_progression 
H-positive risk:  664 664 85 1118 453 95 1090 420 166 48 137 60 
H-negative risk:  664 664 1090 1118 420 453 95 85 137 166 60 48 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
222 
disease_progression 
H-positive risk:  665 661 90 1120 455 95 1085 418 165 51 137 58 
H-negative risk:  661 665 1085 1120 418 455 95 90 137 165 58 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
223 
disease_progression 
H-positive risk:  664 658 89 1117 456 95 1088 416 166 52 136 63 
H-negative risk:  658 664 1088 1117 416 456 95 89 136 166 63 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
224 
disease_progression 
H-positive risk:  669 662 90 1111 454 97 1082 415 168 53 137 62 
H-negative risk:  662 669 1082 1111 415 454 97 90 137 168 62 53 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
225 
disease_progression 
H-positive risk:  661 663 90 1102 470 100 1084 410 166 52 141 61 
H-negative risk:  663 661 1084 1102 410 470 100 90 141 166 61 52 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
226 
disease_progression 
H-positive risk:  658 665 89 1109 467 104 1083 412 165 47 141 60 
H-negative risk:  665 658 1083 1109 412 467 104 89 141 165 60 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 89 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
227 
disease_progression 
H-positive risk:  654 665 89 1104 467 105 1092 410 164 48 140 62 
H-negative risk:  665 654 1092 1104 410 467 105 89 140 164 62 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 88 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
228 
disease_progression 
H-positive risk:  656 663 90 1102 468 105 1087 418 162 49 140 60 
H-negative risk:  663 656 1087 1102 418 468 105 90 140 162 60 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
52 new agents 
229 
disease_progression 
H-positive risk:  653 652 92 1098 479 103 1073 434 164 51 140 61 
H-negative risk:  652 653 1073 1098 434 479 103 92 140 164 61 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 89 31 

clinical_engagement 
diagnosis 
demography 
98 new agents 
230 
disease_progression 
H-positive risk:  665 650 89 1102 470 105 1070 431 164 51 139 64 
H-negative risk:  650 665 1070 1102 431 470 105 89 139 164 64 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
79 new agents 
231 
disease_progression 
H-positive risk:  655 650 87 1102 477 104 1078 426 163 54 141 63 
H-negative risk:  650 655 1078 1102 426 477 104 87 141 163 63 54 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 92 32 

clinical_engagement 
diagnosis 
demography 
75 new agents 
232 
disease_progression 
H-positive risk:  662 651 87 1099 470 103 1075 426 165 56 141 65 
H-negative risk:  651 662 1075 1099 426 470 103 87 141 165 65 56 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
233 
disease_progression 
H-positive risk:  665 655 88 1097 470 101 1074 426 167 54 142 61 
H-negative risk:  655 665 1074 1097 426 470 101 88 142 167 61 54 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 93 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
234 
disease_progression 
H-positive risk:  659 658 85 1095 472 103 1080 418 167 55 147 61 
H-negative risk:  658 659 1080 1095 418 472 103 85 147 167 61 55 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 92 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
235 
disease_progression 
H-positive risk:  666 662 87 1085 475 104 1077 420 165 52 143 64 
H-negative risk:  662 666 1077 1085 420 475 104 87 143 165 64 52 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 94 29 

clinical_engagement 
diagnosis 
demography 
84 new agents 
236 
disease_progression 
H-positive risk:  662 661 84 1094 469 98 1076 432 171 48 143 62 
H-negative risk:  661 662 1076 1094 432 469 98 84 143 171 62 48 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
237 
disease_progression 
H-positive risk:  656 669 87 1079 472 98 1093 423 170 48 141 64 
H-negative risk:  669 656 1093 1079 423 472 98 87 141 170 64 48 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
238 
disease_progression 
H-positive risk:  661 672 90 1075 468 96 1080 431 169 52 139 67 
H-negative risk:  672 661 1080 1075 431 468 96 90 139 169 67 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
239 
disease_progression 
H-positive risk:  660 680 92 1071 464 93 1078 433 175 49 138 67 
H-negative risk:  680 660 1078 1071 433 464 93 92 138 175 67 49 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
240 
disease_progression 
H-positive risk:  658 684 92 1078 467 94 1067 437 169 49 136 69 
H-negative risk:  684 658 1067 1078 437 467 94 92 136 169 69 49 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
241 
disease_progression 
H-positive risk:  661 680 95 1066 478 92 1055 451 171 47 136 68 
H-negative risk:  680 661 1055 1066 451 478 92 95 136 171 68 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
242 
disease_progression 
H-positive risk:  664 682 92 1061 472 93 1058 451 169 49 139 70 
H-negative risk:  682 664 1058 1061 451 472 93 92 139 169 70 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
89 new agents 
243 
disease_progression 
H-positive risk:  662 678 90 1065 468 95 1062 450 170 50 140 70 
H-negative risk:  678 662 1062 1065 450 468 95 90 140 170 70 50 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
244 
disease_progression 
H-positive risk:  675 675 93 1056 471 95 1055 453 169 50 139 69 
H-negative risk:  675 675 1055 1056 453 471 95 93 139 169 69 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
245 
disease_progression 
H-positive risk:  679 683 95 1056 465 95 1062 447 166 49 136 67 
H-negative risk:  683 679 1062 1056 447 465 95 95 136 166 67 49 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
246 
disease_progression 
H-positive risk:  683 688 93 1056 457 95 1062 447 165 50 135 69 
H-negative risk:  688 683 1062 1056 447 457 95 93 135 165 69 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
247 
disease_progression 
H-positive risk:  691 687 97 1059 453 94 1059 442 165 49 134 70 
H-negative risk:  687 691 1059 1059 442 453 94 97 134 165 70 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
248 
disease_progression 
H-positive risk:  699 684 99 1055 455 95 1049 448 163 50 136 67 
H-negative risk:  684 699 1049 1055 448 455 95 99 136 163 67 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
249 
disease_progression 
H-positive risk:  701 678 100 1051 450 101 1047 456 159 52 138 67 
H-negative risk:  678 701 1047 1051 456 450 101 100 138 159 67 52 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
93 new agents 
250 
disease_progression 
H-positive risk:  695 677 100 1056 450 100 1048 465 158 51 134 66 
H-negative risk:  677 695 1048 1056 465 450 100 100 134 158 66 51 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 92 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
251 
disease_progression 
H-positive risk:  694 676 99 1063 446 98 1052 462 159 50 136 65 
H-negative risk:  676 694 1052 1063 462 446 98 99 136 159 65 50 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
60 new agents 
252 
disease_progression 
H-positive risk:  696 682 101 1059 450 99 1053 452 158 49 137 64 
H-negative risk:  682 696 1053 1059 452 450 99 101 137 158 64 49 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 92 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
253 
disease_progression 
H-positive risk:  704 675 99 1051 450 98 1058 455 161 49 138 62 
H-negative risk:  675 704 1058 1051 455 450 98 99 138 161 62 49 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
95 new agents 
254 
disease_progression 
H-positive risk:  694 678 101 1058 441 95 1076 447 164 47 135 64 
H-negative risk:  678 694 1076 1058 447 441 95 101 135 164 64 47 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 91 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
255 
disease_progression 
H-positive risk:  686 675 106 1061 438 96 1081 446 164 48 135 64 
H-negative risk:  675 686 1081 1061 446 438 96 106 135 164 64 48 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 96 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
256 
disease_progression 
H-positive risk:  689 677 104 1055 443 92 1078 447 164 49 140 62 
H-negative risk:  677 689 1078 1055 447 443 92 104 140 164 62 49 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 95 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
257 
disease_progression 
H-positive risk:  689 683 103 1053 436 91 1078 449 165 50 142 61 
H-negative risk:  683 689 1078 1053 449 436 91 103 142 165 61 50 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
258 
disease_progression 
H-positive risk:  689 683 102 1059 439 92 1072 447 164 51 142 60 
H-negative risk:  683 689 1072 1059 447 439 92 102 142 164 60 51 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
259 
disease_progression 
H-positive risk:  693 683 103 1059 432 91 1065 456 164 51 143 60 
H-negative risk:  683 693 1065 1059 456 432 91 103 143 164 60 51 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 96 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
260 
disease_progression 
H-positive risk:  699 692 102 1051 430 93 1061 454 162 50 146 60 
H-negative risk:  692 699 1061 1051 454 430 93 102 146 162 60 50 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 95 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
261 
disease_progression 
H-positive risk:  706 690 101 1047 426 99 1059 448 167 50 149 58 
H-negative risk:  690 706 1059 1047 448 426 99 101 149 167 58 50 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 94 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
262 
disease_progression 
H-positive risk:  708 689 104 1052 420 99 1063 442 166 51 149 57 
H-negative risk:  689 708 1063 1052 442 420 99 104 149 166 57 51 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
263 
disease_progression 
H-positive risk:  714 696 106 1049 427 94 1052 437 165 54 147 59 
H-negative risk:  696 714 1052 1049 437 427 94 106 147 165 59 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
264 
disease_progression 
H-positive risk:  718 702 107 1047 420 94 1056 430 166 53 145 62 
H-negative risk:  702 718 1056 1047 430 420 94 107 145 166 62 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
265 
disease_progression 
H-positive risk:  724 706 106 1042 420 94 1054 428 165 53 145 63 
H-negative risk:  706 724 1054 1042 428 420 94 106 145 165 63 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
266 
disease_progression 
H-positive risk:  725 699 107 1043 422 94 1058 429 166 52 142 63 
H-negative risk:  699 725 1058 1043 429 422 94 107 142 166 63 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
267 
disease_progression 
H-positive risk:  726 696 106 1054 420 93 1055 425 165 53 145 62 
H-negative risk:  696 726 1055 1054 425 420 93 106 145 165 62 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  725 693 104 1057 419 93 1056 421 168 53 150 61 
H-negative risk:  693 725 1056 1057 421 419 93 104 150 168 61 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  721 685 107 1070 418 93 1060 415 170 53 148 60 
H-negative risk:  685 721 1060 1070 415 418 93 107 148 170 60 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
270 
disease_progression 
H-positive risk:  722 689 103 1066 419 91 1059 414 171 53 152 61 
H-negative risk:  689 722 1059 1066 414 419 91 103 152 171 61 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
52 new agents 
271 
disease_progression 
H-positive risk:  719 690 99 1069 419 91 1056 418 167 56 154 62 
H-negative risk:  690 719 1056 1069 418 419 91 99 154 167 62 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
272 
disease_progression 
H-positive risk:  716 691 99 1067 415 94 1063 412 165 58 158 62 
H-negative risk:  691 716 1063 1067 412 415 94 99 158 165 62 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
273 
disease_progression 
H-positive risk:  715 685 97 1071 419 95 1066 410 164 60 155 63 
H-negative risk:  685 715 1066 1071 410 419 95 97 155 164 63 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
274 
disease_progression 
H-positive risk:  717 689 96 1071 406 94 1064 418 166 60 156 63 
H-negative risk:  689 717 1064 1071 418 406 94 96 156 166 63 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
275 
disease_progression 
H-positive risk:  714 684 99 1079 408 95 1060 418 165 59 154 65 
H-negative risk:  684 714 1060 1079 418 408 95 99 154 165 65 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
93 new agents 
276 
disease_progression 
H-positive risk:  717 688 103 1076 402 96 1062 415 161 62 154 64 
H-negative risk:  688 717 1062 1076 415 402 96 103 154 161 64 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
277 
disease_progression 
H-positive risk:  724 682 102 1074 412 97 1061 409 164 62 153 60 
H-negative risk:  682 724 1061 1074 409 412 97 102 153 164 60 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
278 
disease_progression 
H-positive risk:  718 683 104 1087 413 96 1059 399 166 65 149 61 
H-negative risk:  683 718 1059 1087 399 413 96 104 149 166 61 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
279 
disease_progression 
H-positive risk:  716 679 104 1089 412 97 1059 404 164 65 150 61 
H-negative risk:  679 716 1059 1089 404 412 97 104 150 164 61 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
280 
disease_progression 
H-positive risk:  725 678 103 1091 417 98 1045 398 166 67 152 60 
H-negative risk:  678 725 1045 1091 398 417 98 103 152 166 60 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
281 
disease_progression 
H-positive risk:  727 672 99 1091 417 95 1045 405 164 70 151 64 
H-negative risk:  672 727 1045 1091 405 417 95 99 151 164 64 70 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
282 
disease_progression 
H-positive risk:  729 676 100 1090 416 94 1051 399 165 67 152 61 
H-negative risk:  676 729 1051 1090 399 416 94 100 152 165 61 67 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
283 
disease_progression 
H-positive risk:  731 678 102 1084 413 95 1053 400 164 67 152 61 
H-negative risk:  678 731 1053 1084 400 413 95 102 152 164 61 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
284 
disease_progression 
H-positive risk:  728 674 105 1078 419 90 1063 402 166 65 150 60 
H-negative risk:  674 728 1063 1078 402 419 90 105 150 166 60 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
285 
disease_progression 
H-positive risk:  732 675 105 1076 414 89 1069 399 168 63 149 61 
H-negative risk:  675 732 1069 1076 399 414 89 105 149 168 61 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
286 
disease_progression 
H-positive risk:  733 672 103 1083 420 90 1075 391 165 60 145 63 
H-negative risk:  672 733 1075 1083 391 420 90 103 145 165 63 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
287 
disease_progression 
H-positive risk:  729 668 106 1092 418 91 1075 389 159 62 146 65 
H-negative risk:  668 729 1075 1092 389 418 91 106 146 159 65 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
288 
disease_progression 
H-positive risk:  740 665 109 1090 417 91 1070 390 161 58 146 63 
H-negative risk:  665 740 1070 1090 390 417 91 109 146 161 63 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 81 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
289 
disease_progression 
H-positive risk:  735 662 106 1099 409 92 1068 400 163 58 145 63 
H-negative risk:  662 735 1068 1099 400 409 92 106 145 163 63 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 80 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
290 
disease_progression 
H-positive risk:  728 664 107 1110 401 90 1068 399 165 57 147 64 
H-negative risk:  664 728 1068 1110 399 401 90 107 147 165 64 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
85 new agents 
291 
disease_progression 
H-positive risk:  723 675 105 1115 396 89 1060 405 166 55 145 66 
H-negative risk:  675 723 1060 1115 405 396 89 105 145 166 66 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 83 31 

clinical_engagement 
diagnosis 
demography 
90 new agents 
292 
disease_progression 
H-positive risk:  724 667 105 1128 396 88 1048 414 166 53 143 68 
H-negative risk:  667 724 1048 1128 414 396 88 105 143 166 68 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 82 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
293 
disease_progression 
H-positive risk:  721 665 104 1132 389 87 1049 421 168 55 139 70 
H-negative risk:  665 721 1049 1132 421 389 87 104 139 168 70 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
294 
disease_progression 
H-positive risk:  719 663 102 1131 380 88 1063 416 168 55 146 69 
H-negative risk:  663 719 1063 1131 416 380 88 102 146 168 69 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
82 new agents 
295 
disease_progression 
H-positive risk:  714 662 103 1129 378 91 1066 423 166 56 143 69 
H-negative risk:  662 714 1066 1129 423 378 91 103 143 166 69 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
296 
disease_progression 
H-positive risk:  702 664 104 1137 384 88 1074 416 165 56 141 69 
H-negative risk:  664 702 1074 1137 416 384 88 104 141 165 69 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
297 
disease_progression 
H-positive risk:  697 668 103 1136 384 87 1070 421 165 58 144 67 
H-negative risk:  668 697 1070 1136 421 384 87 103 144 165 67 58 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
298 
disease_progression 
H-positive risk:  712 666 102 1140 389 88 1060 416 165 56 144 62 
H-negative risk:  666 712 1060 1140 416 389 88 102 144 165 62 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
299 
disease_progression 
H-positive risk:  708 664 100 1140 392 88 1058 425 163 54 143 65 
H-negative risk:  664 708 1058 1140 425 392 88 100 143 163 65 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
300 
disease_progression 
H-positive risk:  702 659 101 1143 395 86 1064 424 163 56 142 65 
H-negative risk:  659 702 1064 1143 424 395 86 101 142 163 65 56 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
80 new agents 
301 
disease_progression 
H-positive risk:  703 653 99 1151 402 84 1064 419 163 55 142 65 
H-negative risk:  653 703 1064 1151 419 402 84 99 142 163 65 55 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 76 35 

clinical_engagement 
diagnosis 
demography 
80 new agents 
302 
disease_progression 
H-positive risk:  695 655 101 1156 394 87 1070 415 165 55 141 66 
H-negative risk:  655 695 1070 1156 415 394 87 101 141 165 66 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 76 32 

clinical_engagement 
diagnosis 
demography 
66 new agents 
303 
disease_progression 
H-positive risk:  694 660 99 1145 402 86 1059 422 166 56 144 67 
H-negative risk:  660 694 1059 1145 422 402 86 99 144 166 67 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
304 
disease_progression 
H-positive risk:  693 659 98 1156 391 89 1067 410 164 57 149 67 
H-negative risk:  659 693 1067 1156 410 391 89 98 149 164 67 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
305 
disease_progression 
H-positive risk:  691 665 96 1152 393 89 1068 414 162 56 148 66 
H-negative risk:  665 691 1068 1152 414 393 89 96 148 162 66 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
306 
disease_progression 
H-positive risk:  693 660 98 1156 399 89 1061 418 159 56 147 64 
H-negative risk:  660 693 1061 1156 418 399 89 98 147 159 64 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
307 
disease_progression 
H-positive risk:  690 663 96 1158 397 87 1063 414 163 56 151 62 
H-negative risk:  663 690 1063 1158 414 397 87 96 151 163 62 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
308 
disease_progression 
H-positive risk:  685 670 94 1154 395 88 1061 420 165 54 153 61 
H-negative risk:  670 685 1061 1154 420 395 88 94 153 165 61 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
309 
disease_progression 
H-positive risk:  683 675 93 1152 390 86 1061 418 168 53 156 65 
H-negative risk:  675 683 1061 1152 418 390 86 93 156 168 65 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 79 32 

clinical_engagement 
diagnosis 
demography 
72 new agents 
310 
disease_progression 
H-positive risk:  689 679 92 1144 389 87 1062 413 168 53 158 66 
H-negative risk:  679 689 1062 1144 413 389 87 92 158 168 66 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 77 35 

clinical_engagement 
diagnosis 
demography 
67 new agents 
311 
disease_progression 
H-positive risk:  690 677 93 1144 394 84 1061 415 168 51 158 65 
H-negative risk:  677 690 1061 1144 415 394 84 93 158 168 65 51 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
84 new agents 
312 
disease_progression 
H-positive risk:  695 681 89 1154 386 83 1047 416 171 52 161 65 
H-negative risk:  681 695 1047 1154 416 386 83 89 161 171 65 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
313 
disease_progression 
H-positive risk:  702 682 88 1146 389 84 1053 408 169 54 162 63 
H-negative risk:  682 702 1053 1146 408 389 84 88 162 169 63 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 77 32 

clinical_engagement 
diagnosis 
demography 
85 new agents 
314 
disease_progression 
H-positive risk:  707 684 86 1136 392 85 1061 404 164 53 164 64 
H-negative risk:  684 707 1061 1136 404 392 85 86 164 164 64 53 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 78 33 

clinical_engagement 
diagnosis 
demography 
72 new agents 
315 
disease_progression 
H-positive risk:  710 684 89 1132 402 87 1059 396 167 51 159 64 
H-negative risk:  684 710 1059 1132 396 402 87 89 159 167 64 51 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 79 34 

clinical_engagement 
diagnosis 
demography 
75 new agents 
316 
disease_progression 
H-positive risk:  709 682 85 1138 400 86 1063 398 168 51 162 58 
H-negative risk:  682 709 1063 1138 398 400 86 85 162 168 58 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
87 new agents 
317 
disease_progression 
H-positive risk:  711 685 87 1133 401 87 1058 401 170 51 155 61 
H-negative risk:  685 711 1058 1133 401 401 87 87 155 170 61 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
318 
disease_progression 
H-positive risk:  708 688 89 1128 407 87 1067 394 168 50 157 57 
H-negative risk:  688 708 1067 1128 394 407 87 89 157 168 57 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
319 
disease_progression 
H-positive risk:  711 684 90 1128 404 86 1076 395 168 47 155 56 
H-negative risk:  684 711 1076 1128 395 404 86 90 155 168 56 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
82 new agents 
320 
disease_progression 
H-positive risk:  721 679 91 1129 406 86 1072 393 171 47 151 54 
H-negative risk:  679 721 1072 1129 393 406 86 91 151 171 54 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
321 
disease_progression 
H-positive risk:  731 687 93 1125 410 86 1060 386 168 47 151 56 
H-negative risk:  687 731 1060 1125 386 410 86 93 151 168 56 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
322 
disease_progression 
H-positive risk:  725 684 92 1113 410 84 1067 399 171 49 148 58 
H-negative risk:  684 725 1067 1113 399 410 84 92 148 171 58 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
323 
disease_progression 
H-positive risk:  724 685 92 1115 418 81 1067 395 168 49 145 61 
H-negative risk:  685 724 1067 1115 395 418 81 92 145 168 61 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
324 
disease_progression 
H-positive risk:  730 680 91 1118 413 81 1066 398 170 51 145 57 
H-negative risk:  680 730 1066 1118 398 413 81 91 145 170 57 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
325 
disease_progression 
H-positive risk:  726 680 89 1113 417 84 1076 393 167 53 146 56 
H-negative risk:  680 726 1076 1113 393 417 84 89 146 167 56 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
75 new agents 
326 
disease_progression 
H-positive risk:  732 682 90 1106 424 87 1065 397 163 54 146 54 
H-negative risk:  682 732 1065 1106 397 424 87 90 146 163 54 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
88 new agents 
327 
disease_progression 
H-positive risk:  734 685 90 1102 426 85 1059 398 166 55 147 53 
H-negative risk:  685 734 1059 1102 398 426 85 90 147 166 53 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
328 
disease_progression 
H-positive risk:  730 683 87 1098 431 86 1066 396 166 56 146 55 
H-negative risk:  683 730 1066 1098 396 431 86 87 146 166 55 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
54 new agents 
329 
disease_progression 
H-positive risk:  730 686 86 1083 436 85 1062 402 164 61 147 58 
H-negative risk:  686 730 1062 1083 402 436 85 86 147 164 58 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
67 new agents 
330 
disease_progression 
H-positive risk:  731 682 86 1090 432 85 1061 401 162 59 152 59 
H-negative risk:  682 731 1061 1090 401 432 85 86 152 162 59 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 60 33 

clinical_engagement 
diagnosis 
demography 
61 new agents 
331 
disease_progression 
H-positive risk:  723 690 86 1090 432 83 1060 407 161 55 153 60 
H-negative risk:  690 723 1060 1090 407 432 83 86 153 161 60 55 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 61 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
332 
disease_progression 
H-positive risk:  710 695 87 1092 436 82 1056 411 161 56 155 59 
H-negative risk:  695 710 1056 1092 411 436 82 87 155 161 59 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 64 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
333 
disease_progression 
H-positive risk:  704 703 88 1095 432 82 1051 417 161 57 153 57 
H-negative risk:  703 704 1051 1095 417 432 82 88 153 161 57 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
334 
disease_progression 
H-positive risk:  708 704 87 1097 431 83 1037 427 161 56 152 57 
H-negative risk:  704 708 1037 1097 427 431 83 87 152 161 57 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
335 
disease_progression 
H-positive risk:  714 702 85 1105 435 81 1029 426 160 53 154 56 
H-negative risk:  702 714 1029 1105 426 435 81 85 154 160 56 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
336 
disease_progression 
H-positive risk:  713 703 83 1096 444 86 1032 423 159 54 154 53 
H-negative risk:  703 713 1032 1096 423 444 86 83 154 159 53 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 65 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  713 712 81 1094 441 87 1022 431 156 53 153 57 
H-negative risk:  712 713 1022 1094 431 441 87 81 153 156 57 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 65 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
338 
disease_progression 
H-positive risk:  712 707 79 1098 446 88 1026 420 157 53 155 59 
H-negative risk:  707 712 1026 1098 420 446 88 79 155 157 59 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 65 30 

clinical_engagement 
diagnosis 
demography 
78 new agents 
339 
disease_progression 
H-positive risk:  712 705 81 1101 446 92 1025 425 152 53 150 58 
H-negative risk:  705 712 1025 1101 425 446 92 81 150 152 58 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 64 30 

clinical_engagement 
diagnosis 
demography 
63 new agents 
340 
disease_progression 
H-positive risk:  712 696 79 1105 452 95 1018 426 152 55 151 59 
H-negative risk:  696 712 1018 1105 426 452 95 79 151 152 59 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
341 
disease_progression 
H-positive risk:  713 703 82 1107 443 95 1016 429 147 55 151 59 
H-negative risk:  703 713 1016 1107 429 443 95 82 151 147 59 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 66 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
342 
disease_progression 
H-positive risk:  722 709 86 1107 437 92 1007 429 147 54 152 58 
H-negative risk:  709 722 1007 1107 429 437 92 86 152 147 58 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 69 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
343 
disease_progression 
H-positive risk:  721 705 83 1110 432 92 1014 427 148 54 155 59 
H-negative risk:  705 721 1014 1110 427 432 92 83 155 148 59 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
344 
disease_progression 
H-positive risk:  718 715 83 1109 424 92 1019 424 148 50 157 61 
H-negative risk:  715 718 1019 1109 424 424 92 83 157 148 61 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 69 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
345 
disease_progression 
H-positive risk:  719 718 83 1109 421 91 1028 412 149 49 158 63 
H-negative risk:  718 719 1028 1109 412 421 91 83 158 149 63 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
79 new agents 
346 
disease_progression 
H-positive risk:  713 731 81 1103 425 95 1020 413 151 47 158 63 
H-negative risk:  731 713 1020 1103 413 425 95 81 158 151 63 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
347 
disease_progression 
H-positive risk:  719 728 85 1108 428 95 1021 404 145 46 160 61 
H-negative risk:  728 719 1021 1108 404 428 95 85 160 145 61 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 75 35 

clinical_engagement 
diagnosis 
demography 
85 new agents 
348 
disease_progression 
H-positive risk:  712 727 85 1102 432 94 1030 401 151 46 162 58 
H-negative risk:  727 712 1030 1102 401 432 94 85 162 151 58 46 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
349 
disease_progression 
H-positive risk:  705 730 87 1104 429 93 1037 401 153 46 161 54 
H-negative risk:  730 705 1037 1104 401 429 93 87 161 153 54 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 71 33 

clinical_engagement 
diagnosis 
demography 
85 new agents 
350 
disease_progression 
H-positive risk:  706 733 90 1102 429 94 1034 396 153 51 159 53 
H-negative risk:  733 706 1034 1102 396 429 94 90 159 153 53 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
351 
disease_progression 
H-positive risk:  704 730 92 1104 429 95 1032 396 154 50 161 53 
H-negative risk:  730 704 1032 1104 396 429 95 92 161 154 53 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
352 
disease_progression 
H-positive risk:  698 732 92 1097 435 94 1037 394 155 52 156 58 
H-negative risk:  732 698 1037 1097 394 435 94 92 156 155 58 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
353 
disease_progression 
H-positive risk:  698 724 93 1094 446 92 1038 388 156 52 162 57 
H-negative risk:  724 698 1038 1094 388 446 92 93 162 156 57 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
354 
disease_progression 
H-positive risk:  693 724 92 1099 442 93 1048 382 160 49 162 56 
H-negative risk:  724 693 1048 1099 382 442 93 92 162 160 56 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
67 new agents 
355 
disease_progression 
H-positive risk:  697 719 92 1097 442 92 1048 384 160 47 165 57 
H-negative risk:  719 697 1048 1097 384 442 92 92 165 160 57 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
356 
disease_progression 
H-positive risk:  701 718 92 1105 435 93 1048 379 159 47 165 58 
H-negative risk:  718 701 1048 1105 379 435 93 92 165 159 58 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
357 
disease_progression 
H-positive risk:  702 711 90 1108 440 92 1038 390 159 48 161 61 
H-negative risk:  711 702 1038 1108 390 440 92 90 161 159 61 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
358 
disease_progression 
H-positive risk:  700 713 89 1104 451 91 1038 384 156 52 160 62 
H-negative risk:  713 700 1038 1104 384 451 91 89 160 156 62 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
359 
disease_progression 
H-positive risk:  696 713 88 1110 442 94 1048 383 154 54 158 60 
H-negative risk:  713 696 1048 1110 383 442 94 88 158 154 60 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
360 
disease_progression 
H-positive risk:  693 714 89 1121 434 93 1040 388 154 56 159 59 
H-negative risk:  714 693 1040 1121 388 434 93 89 159 154 59 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
Time difference of 17.52432 mins
This is task 16
